Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| QuoteWell | 2025 | Series A | $12.0M | Austin |
| Zenas BioPharma | 2025 | Post Ipo Equity | $120.0M | Waltham |
| Affinia Therapeutics | 2025 | Series C | $40.0M | Waltham |
| Djust | 2025 | Series A | $8.2M | Paris |
| Zania | 2025 | Series A | $18.0M | Palo Alto |
| Flox | 2025 | Series B | $24.9M | New York |
| Augment Markets | 2025 | Series A | $16.5M | Austin |
| Factory | 2025 | Series B | $50.0M | San Francisco |
| Brale | 2025 | Seed | $30.0M | Des Moines |
| Celcuity | 2025 | Post Ipo Debt | $500.0M | Hamel |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 151 | QuoteWell | Series A | $12.0M | Austin, United States |
| 152 | Zenas BioPharma | Post Ipo Equity | $120.0M | Waltham, United States |
| 153 | Affinia Therapeutics | Series C | $40.0M | Waltham, United States |
| 154 | Djust | Series A | $8.2M | Paris, France |
| 155 | Zania | Series A | $18.0M | Palo Alto, United States |
| 156 | Flox | Series B | $24.9M | New York, United States |
| 157 | Augment Markets | Series A | $16.5M | Austin, United States |
| 158 | Factory | Series B | $50.0M | San Francisco, United States |
| 159 | Brale | Seed | $30.0M | Des Moines, United States |
| 160 | Celcuity | Post Ipo Debt | $500.0M | Hamel, United States |
QuoteWell is a digital-first platform that meets the demands of the contemporary insurance sector.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
DJUST is a digital B2B e-commerce platform.
Autonomous AI agents for Security Risk and Compliance
Flox offers developers, platform engineers, and operators reproducible environments that span the enterprise SDLC. Bringing Nix to Work!
Augment Markets is a pre-IPO marketplace that enables investors to buy and sell shares in private companies.
Factory provides AI software agents automating complex development tasks and workflows.
Brale provides a platform for issuing and managing stablecoins on multiple blockchain networks.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Charm Therapeutics designs and develops small-molecule therapeutics that target the interaction between menin and the KMT2A protein.
Building the world's best financial advisor, powered by AI (free options for individuals)
Wheels Up is a membership-based private aviation company that focuses on reducing upfront cost to fly privately.
Aurelian is an AI platform designed to automate routes, triage, and resolve non-emergency police calls.
Bluefish helps brands turn AI into a powerful new marketing channel to reach consumers and tell their story online.
Ursa Space Systems is a satellite intelligence company that provides data solutions and analytic services.
Ohai.ai provides an AI-powered assistant that manages household schedules and coordinates family calendars.
Aigen is a robotics company that creates small edge-based robots.
Elion is a digital health software marketplace for healthcare providers.
Courtyard is an online marketplace for trading cards & digital packs
Swift Navigation is a technology company that provides precise positioning solutions for advanced automotive driver-assistance systems.
Genie is a provider of a Shopify inventory management solution for fast-growing merchants.
NG.CASH is a digital bank for the next generation, helping them master their money and make smarter financial choices every day.
Belong Health works with local health plans to provide regionally informed, humanistic care to a rapidly expanding community of need.
New Enterprise Associates has invested in 461 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
New Enterprise Associates's top investment sectors include Software, Artificial Intelligence (AI), Health Care, Information Technology, Biotechnology. The firm invests across 47 different industry categories.
Among tracked funding rounds, Celcuity received $500.0M in a Post Ipo Debt round. New Enterprise Associates's total known invested capital is $23.0B.
New Enterprise Associates's average investment size is $69.4M across its portfolio of 461 companies.
Recent New Enterprise Associates portfolio additions include QuoteWell, Zenas BioPharma, Affinia Therapeutics, Djust, Zania. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors